Laserfiche WebLink
CANNABIS CONSUMERS IN AMERICA 2023: PART 114 © New Frontier Data, All Rights Reserved. <br />Chronic pain <br />Migraines <br />PTSD <br />Osteoarthritis <br />Rheumatoid arthritis <br />Neuropathy <br />IBS <br />Fibromyalgia <br />Cancer <br />Autism <br />Glaucoma <br />Seizures/epilepsy <br />Anorexia nervosa <br />Crohn's disease <br />46% <br />21% <br />17% <br />10% <br />9% <br />9% <br />5% <br />5% <br />5% <br />4% <br />3% <br />3% <br />3% <br />3% <br />Medical Consumers <br />While more consumers <br />consider themselves <br />broadly “recreational” than <br />“medical” cannabis users, <br />a majority (53%) describe <br />their cannabis use as both <br />medical and recreational. <br />Self-Identified User Type <br />Diagnosed Medical Conditions Being Treated with Cannabis <br />75% <br />of self-identified medical consumers say they are treating a specific medical condition a diagnosed by a doctor. <br />42% <br />MEDICAL <br />53% <br />DUAL USE <br />58% <br />RECREATIONAL <br />Exclusivelymedical <br />Primarilymedical <br />Primarilyrecreational <br />Exclusivelyrecreational <br />15% <br />28% <br />25% <br />32% <br />Among current (annual+) consumers who describe their use as primarily or exclusively medical. <br />Page 220 of 322